Advertisement · 728 × 90

Posts by Grace Macaulay

Post image Post image

Great to host the London School of Paediatrics Research Evening last week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team!🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch

4 months ago 0 0 0 0
Post image

Oral vaccine protects against Salmonella Paratyphi in human challenge trial

The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever.

www.cidrap.umn.edu/s...

5 months ago 32 12 1 3
Kaplan–Meier curves for a diagnosis after challenge with S. Paratyphi A in a controlled human infection model.

Kaplan–Meier curves for a diagnosis after challenge with S. Paratyphi A in a controlled human infection model.

In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results: nej.md/3Lypfd5

#MedSky #IDSky

5 months ago 7 3 1 2
A visual representation of the VASP phase 2b trial, which assessed a vaccine for protection against S. Paratyphi A infection.

A visual representation of the VASP phase 2b trial, which assessed a vaccine for protection against S. Paratyphi A infection.

VASP phase 2b trial: No vaccine against Salmonella enterica serovar Paratyphi A is currently available. Research findings involving a candidate vaccine are summarized in a new Quick Take video. nej.md/43Gbmjc

#MedSky #IDSky

5 months ago 4 2 0 0
The New England Journal of Medicine                   
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 
A Research Summary based on McCann N et al. | 10.1056/NEJMoa2502992 | Published on October 30, 2025 

Visual representations of the patients in the trial and the treatments they were assigned.    

Read the full Research Summary at NEJM.org.

The New England Journal of Medicine Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine A Research Summary based on McCann N et al. | 10.1056/NEJMoa2502992 | Published on October 30, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.

In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results and Research Summary: nej.md/3Lypfd5 

#MedSky

5 months ago 9 3 1 1
Preview
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006) Paediatric COVID-19 vaccination programmes were initiated in response to the coronavirus pandemic declared by the World Health Organisation (WHO) in 2…

New paper out 📣 Final results from the COV006 study - Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years 🦠📊 @grace-li.bsky.social @ox.ac.uk @ovg.ox.ac.uk

www.sciencedirect.com/science/arti...

7 months ago 1 0 0 0

@cinarervanur.bsky.social thanks for contributing!

11 months ago 1 0 1 0
Advertisement
Post image Post image

Great to help host the London School of Paediatrics Research Evening this week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team. 🔬🩺✨
#londonschoolofpaediatrics #paediatricresearch

11 months ago 0 0 1 1

Happening next week - celebrating paediatric research being done by amazing trainees! ⬇️👏

11 months ago 0 0 0 0
Post image

Our next Paediatric Research Evening brought to you by the London School of Paediatrics🔬🌍🩺

If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️

#paediatricresearch #childhealth

1 year ago 0 0 0 1

Oooh is this presentation available to attend virtually? (Paeds trainee with a keen interest in research 🙋‍♀️)

1 year ago 1 0 0 0

Great to see recruitment open 🦠🌏 Such an important study!
@ox.ac.uk @ovg.ox.ac.uk

1 year ago 3 0 0 0
Preview
Addressing grand ecological challenges in aquatic ecosystems: how can mesocosms be used to advance solutions? Rapid and drastic anthropogenic impacts are affecting global biogeochemical processes and driving biodiversity loss across Earth's ecosystems. In aquatic ecosystems, species distributions are shiftin...

How can mesocosms help tackle grand ecological challenges in aquatic ecosystems? 🌊🌍

Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik....

@oikosjournal.bsky.social

1 year ago 32 19 1 1